Pneumothorax sensitivity
0.9379 proportion
- EndpointSensitivity
- Population1,000 adult chest radiographs in the FDA pneumothorax validation set
- Tested versionRayvolve PTX-PE configuration submitted in K243808
FDA-cleared profile
AZmed · X-ray/Radiography · FDA-cleared (510(k))
Authorized purpose: Passive study-level worklist triage for suspected pneumothorax and/or pleural effusion on adult PA or AP chest X-rays; it is not a proactive specialist alert.
Overview status: Source-reviewed overview
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
Clinical takeaway. Clinical role: Passive study-level worklist triage for suspected pneumothorax and/or pleural effusion on adult PA or AP chest X-rays; it is not a proactive specialist alert.
Evidence takeaway. Evidence from the reviewed source record: The FDA-described validation included 1,000 pneumothorax and 1,000 pleural-effusion radiographs. Pneumothorax sensitivity was 0.9379, specificity 0.9178 and AUC 0.9857. Pleural-effusion sensitivity was 0.9134, specificity 0.9448 and AUC 0.9830. Reported processing times were about 19.43 and 19.56 seconds respectively.
Evidence context not reviewed for this FDA record.
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Evidence
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Separate endpoints and populations; see evidence.metrics.
Separate endpoints and populations; see evidence.metrics.
0.9379 proportion
0.9178 proportion
0.9857 area under ROC curve
0.9134 proportion
0.9448 proportion
0.983 area under ROC curve
19.43 seconds
19.56 seconds
K243808
The two disease endpoints use separate 1,000-study populations; results should not be treated as one pooled disease cohort.
Safety and lifecycle
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
The downloaded exact-ID recall packet contained zero records; this limited result does not establish absence of recall or safety information.
Price not public here; enter your quote
Not verified: Pricing information is recorded but not verified against a resolving source.
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Source context, not route validation: Adult PA or AP chest X-rays received as DICOM studies; the FDA-described validation used 1,000 radiographs for pneumothorax and 1,000 for pleural effusion, with balanced positive and negative case groups.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Field checked 2026-09-07 · FDA 510(k) K243808: Rayvolve PTX-PE
Source context, not route validation: Study-level result is transmitted through a DICOM node/PACS workflow for passive worklist triage.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Field checked 2026-09-07 · FDA 510(k) K243808: Rayvolve PTX-PE
Source context, not route validation: Standalone software connected to the radiology DICOM/PACS workflow; exact local hosting and routing terms are not specified in the public summary.
Scope: Exact FDA submission.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-09-07 · FDA 510(k) K243808: Rayvolve PTX-PE
Source context, not route validation: A passive study-level header or secondary-capture result sent to PACS/DICOM node for worklist triage; no markup is placed on the original image.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Field checked 2026-09-07 · FDA 510(k) K243808: Rayvolve PTX-PE
Unresolved route: A passive study-level header or secondary-capture result sent to PACS/DICOM node for worklist triage; no markup is placed on the original image.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Field checked 2026-09-07 · FDA 510(k) K243808: Rayvolve PTX-PE
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
No tests below have been performed or accepted.
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The cleared output is a study-level header or secondary capture sent through a DICOM node/PACS workflow without markup on the original image.
exact submission · checked 2026-09-07AZmed presents Rayvolve as a radiology AI suite intended to fit clinical imaging workflows; the current page does not establish exact hosting, service levels or version for K243808.
product family · checked 2026-09-06Regulatory identity
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Research record
This audit distinguishes completed source review from fields that have not yet been researched.
Stored candidate metadata was screened; no PubMed or trial IDs were returned for this submission. This is not a full-paper review. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, stored candidate metadata, literature index, trial registry, pubmed, clinical trials, openfda device recall
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
No public price or quote for Rayvolve PTX-PE was reviewed.
License, per-study, subscription and implementation terms were not established.
Bounded web search on 2026-10-26 (query: "AZmed Rayvolve reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists; eligibility depends on payer, site of service and use case.
The reviewed sources do not establish exact-release security controls, retention or assurance documentation.
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
7 sources - 3 history items
Scope: identity, purpose, clinicalUse, modality, anatomy, workflowRole, intendedUsers, careSetting, input, output, limitations, integration, deployment, reportedSensitivity, reportedSpecificity, evidenceMetrics, evidenceStudies
Scope: regulatoryIdentity, modalityContext
Scope: intendedUsers, careSetting, output, reportedSensitivity, reportedSpecificity, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities
Scope: evidenceDiscovery
Scope: evidenceDiscovery, studyStatus
Scope: recallDiscovery, nativeSubmissionMatching
Scope: productFamilyContext, implementationCapabilities
Regulatory record
510(k)
Research record
fda record reviewed
Editorial review
Source-reviewed editorial overlay
Alternatives
Ever Fortune.AI, Co., Ltd.
Authorized purpose: Passive triage of adult AP chest radiographs for an endotracheal-tube tip more than 7 cm above the carina, less than 3 cm above the carina, below the carina in the right or left mainstem, or other listed malposition states.
Vuno Inc.
Authorized purpose: Analyzes adult chest X-rays for suspected pleural effusion and/or pneumothorax and provides case-level PACS or workstation prioritization.
Milvue
Authorized purpose: Passive worklist prioritization for suspected pleural effusion and/or pneumothorax on frontal PA or AP chest radiographs in transitional adolescents aged 18-21 and adults aged 22 years and older; not diagnostic or a rule-out function.
Envisionit DeepAI Ltd
Authorized purpose: Passively triage adult frontal chest X-rays for suspected pleural effusion and/or pneumothorax by providing case-level PACS worklist output; not a standalone clinical-decision tool or a rule-out result.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Open existing correction destinationPermission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.
Correction policy and limits · Public repository change history